Botanix Pharmaceuticals Limited (ASX:BOT)
Australia
· Delayed Price · Currency is AUD 0.4200
-0.0050 (-1.18%)
Apr 24, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Revenue
Botanix Pharmaceuticals had revenue of 377.60K AUD in the half year ending December 31, 2024, a decrease of -89.83%. This brings the company's revenue in the last twelve months to 2.07M, up 373.26% year-over-year. In the fiscal year ending June 30, 2024, Botanix Pharmaceuticals had annual revenue of 2.07M, down -45.14%.
Revenue (ttm)
2.07M
Revenue Growth
+373.26%
P/S Ratio
396.61
Revenue / Employee
188.10K
Employees
11
Market Cap
820.65M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Botanix Pharmaceuticals News
- 13 days ago - Botanix Pharmaceuticals taps investors for $40m; Euroz, E&P in tow - The Australian Financial Review
- 3 months ago - This media company’s share price is tipped to double - The Australian Financial Review